Polypharmacology in a Single Drug: Multitarget Drugs

Author(s): M. L. Bolognesi

Journal Name: Current Medicinal Chemistry

Volume 20 , Issue 13 , 2013

Become EABM
Become Reviewer


Polypharmacology offers a model for the way drug discovery must evolve to develop therapies most suited to treating currently incurable diseases. It is driven by a worldwide demand for safer, more effective, and affordable medicines against the most complex diseases, and by the failures of modern drug discovery to provide these. Polypharmacology can involve combinations and/or multitarget drugs (MTD). Although not mutually exclusive, my premise is that MTDs have inherent advantages over combinations. This review article focuses on MTDs from a medicinal chemistry perspective. I will explore their use in current clinical practice, their likely application in the future, and the challenges to be overcome to achieve this goal.

Keywords: Multifactorial diseases, Combination therapy, multitarget drug discovery, network pharmacology, multitargetdirected ligands, designed multiple ligands

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [1639 - 1645]
Pages: 7
DOI: 10.2174/0929867311320130004
Price: $65

Article Metrics

PDF: 81